Li Jiang

1.2k total citations
59 papers, 818 citations indexed

About

Li Jiang is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Li Jiang has authored 59 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 19 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Li Jiang's work include Cerebrovascular and Carotid Artery Diseases (19 papers), Vasculitis and related conditions (14 papers) and Cardiovascular Health and Disease Prevention (12 papers). Li Jiang is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (19 papers), Vasculitis and related conditions (14 papers) and Cardiovascular Health and Disease Prevention (12 papers). Li Jiang collaborates with scholars based in China, Australia and United Kingdom. Li Jiang's co-authors include Peng Lv, Hongchen Gu, Caixia Fu, Lili Ma, Dan Li, Wangchuan Xiao, Huiyong Chen, Qingwei Zhang, Peng Lv and Jingjing Zhang and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Li Jiang

57 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Jiang China 16 396 191 146 142 127 59 818
Samir Patel United States 12 214 0.5× 65 0.3× 145 1.0× 163 1.1× 77 0.6× 49 640
Tal Grenader Israel 18 224 0.6× 40 0.2× 198 1.4× 141 1.0× 75 0.6× 64 1.0k
Vicente J. Caride United States 16 183 0.5× 206 1.1× 200 1.4× 148 1.0× 47 0.4× 56 981
Alessandro Ruggiero United Kingdom 16 315 0.8× 187 1.0× 96 0.7× 167 1.2× 31 0.2× 54 1.3k
Stephan A. Schmitz Germany 16 205 0.5× 393 2.1× 141 1.0× 95 0.7× 179 1.4× 24 950
Pierre Weinmann France 15 265 0.7× 229 1.2× 115 0.8× 73 0.5× 47 0.4× 46 780
Alice Ferretti Italy 17 345 0.9× 380 2.0× 234 1.6× 31 0.2× 97 0.8× 63 905
Ferdinand Ploner Austria 14 365 0.9× 229 1.2× 149 1.0× 61 0.4× 44 0.3× 27 1.3k
Siyuan Dong China 16 253 0.6× 53 0.3× 99 0.7× 55 0.4× 98 0.8× 59 928
Yolanda E. Hartman United States 14 293 0.7× 148 0.8× 169 1.2× 37 0.3× 66 0.5× 23 1.1k

Countries citing papers authored by Li Jiang

Since Specialization
Citations

This map shows the geographic impact of Li Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Jiang more than expected).

Fields of papers citing papers by Li Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Jiang. The network helps show where Li Jiang may publish in the future.

Co-authorship network of co-authors of Li Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Li Jiang. A scholar is included among the top collaborators of Li Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Jiang. Li Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Zhang, Shujie Zhang, Jing Li, et al.. (2025). High-risk characteristics of recurrent ischemic stroke after intensive medical management for 6-month follow-up: a histogram study on vessel wall MRI. European Radiology. 35(3). 1313–1324. 3 indexed citations
2.
3.
Zeng, Yan, et al.. (2024). Intra‐ and Peri‐tumoral Radiomics Based on Dynamic Contrast Enhanced‐MRI to Identify Lymph Node Metastasis and Prognosis in Intrahepatic Cholangiocarcinoma. Journal of Magnetic Resonance Imaging. 60(6). 2669–2680. 6 indexed citations
4.
Li, Yong, et al.. (2024). Severe Hypertensive Response to Atropine Therapy for Bradycardia Associated with Dexmedetomidine: Case Report and Literature Review. Clinical Pharmacology Advances and Applications. Volume 16. 27–31. 3 indexed citations
5.
Liu, Yifan, Bin Chen, Junhao Jiang, et al.. (2024). Prognostic Implications of Initial Focal Contrast Enhancement in Acute Type B Intramural Hematoma. Journal of the American College of Cardiology. 83(4). 503–513. 3 indexed citations
6.
Zhang, Qingwei, Peng Lv, Caixia Fu, et al.. (2022). Prediction of new cerebral ischemic lesion after carotid artery stenting: a high-resolution vessel wall MRI-based radiomics analysis. European Radiology. 33(6). 4115–4126. 7 indexed citations
7.
Shi, Zhang, Xiaodan Ye, Yongming Dai, et al.. (2022). Time-of-Flight Intracranial MRA at 3 T versus 5 T versus 7 T: Visualization of Distal Small Cerebral Arteries. Radiology. 306(1). 207–217. 34 indexed citations
8.
Chen, Rongyi, Lingying Ma, Peng Lv, et al.. (2021). Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis. Arthritis Research & Therapy. 23(1). 63–63. 15 indexed citations
9.
Zhao, Ge, Xiao Tang, Hanfei Tang, et al.. (2020). Recent Intraplaque Hemorrhage Is Associated with a Higher Risk of Ipsilateral Cerebral Embolism During Carotid Artery Stenting. World Neurosurgery. 137. e298–e307. 7 indexed citations
10.
Sun, Ying, Xiufang Kong, Xiaomeng Cui, et al.. (2020). The value of interleukin-6 in predicting disease relapse for Takayasu arteritis during 2-year follow-up. Clinical Rheumatology. 39(11). 3417–3425. 6 indexed citations
12.
Sun, Ying, Lili Ma, Huiyong Chen, et al.. (2018). Analysis of predictive factors for treatment resistance and disease relapse in Takayasu’s arteritis. Clinical Rheumatology. 37(10). 2789–2795. 8 indexed citations
13.
14.
Shan, Yan, Li Jiang, Pengju Xu, et al.. (2014). The combined effect of hypertension and type 2 diabetes mellitus on aortic stiffness and endothelial dysfunction: An integrated study with high-resolution MRI. Magnetic Resonance Imaging. 32(3). 211–216. 6 indexed citations
16.
Zhao, Xiaolong, Lili Chen, Li Jiang, et al.. (2011). An increased level of haemoglobin A1C predicts a poorer clinical outcome in patients with acute pancreatitis. Clinical Endocrinology. 77(2). 241–245. 18 indexed citations
17.
Jiang, Li, et al.. (2008). Rehmannia inhibits adipocyte differentiation and adipogenesis. Biochemical and Biophysical Research Communications. 371(2). 185–190. 23 indexed citations
18.
Jiang, Li, et al.. (2005). Vena Cava 3D Contrast-Enhanced MR Venography: A Pictorial Review. CardioVascular and Interventional Radiology. 28(6). 795–805. 15 indexed citations
19.
Jiang, Li, et al.. (2003). 3D contrast-enhanced MR portography and direct X-ray portography: a correlation study. European Radiology. 13(6). 1277–1285. 5 indexed citations
20.
Jiang, Li. (2003). Budd-Chiari syndrome: Diagnosis with three-dimensional contrast-enhanced magnetic resonance angiography. World Journal of Gastroenterology. 9(10). 2317–2317. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026